KKKiran Kakarala

Kiran Kakarala

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kiran Kakarala has a total of 159 co-authors. Here are the top co-authors by number of shared publications:

  • Yelizaveta Shnayder

    Department of Otolaryngology – Head and Neck Surgery University of Kansas Medical Center Kansas City Kansas USA

    11 shared publications
  • Andres M. Bur

    Department of Otolaryngology – Head and Neck Surgery University of Kansas Medical Center Kansas City Kansas USA

    8 shared publications
  • Terance T. Tsue

    Department of Otolaryngology, Head and Neck Surgery, The University of Kansas Medical Center, Kansas City, Kansas, USA

    7 shared publications
  • Kevin J. Sykes

    Department of Otolaryngology – Head and Neck Surgery University of Kansas Medical Center Kansas City Kansas USA

    6 shared publications
  • William C. Faquin

    Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.

    6 shared publications
  • Douglas A. Girod

    Department of Otolaryngology–Head and Neck Surgery University of Kansas Medical Center Kansas City Kansas U.S.A

    5 shared publications

Latest Publications

  • ASO Visual Abstract: Key Updates on the Version 9 AJCC/UICC Staging System for Salivary Gland Carcinoma

    by Shao Hui Huang, Raja R. Seethala, Snehal G. Patel, Brian O’SUllivan, William Lydiatt, Allen S. Ho, Ali Hosni, Vincent Vander Poorten, Christine M. Glastonbury, Justin Bishop, et al.


  • Outcomes of Microvascular Free Flap Reconstruction With One Versus Two Primary Surgeons

    by Jamison Macke, Tuleen Sawaf, Natalie Schelbar, Bryan Renslo, Heather Schopper, Kevin J. Sykes, Andres Bur, Justin Bond, Yelizaveta Shnayder, Terance T. Tsue, et al.

    Objective: To evaluate operative efficiency and quality in head and neck free flap reconstruction with one versus two primary surgeons by comparing procedure duration, hospital length of stay, complications and readmission rates.Study Design: Retrospective chart review.Setting: Single‐institution tertiary care centre.Methods: A total of 583 patients who received head and neck surgery with free flap reconstruction at the University of Kansas Medical Center between November 2010 and January 2021 were stratified into two cohorts: one‐surgeon cohort and two‐surgeon cohort. In the two‐surgeon cohort, one surgeon performed tissue resection and the second performed reconstruction (n = 329), whereas one primary surgeon performed both resection and reconstruction in the one‐surgeon cohort (n = 254). Patient age, sex, American Society of Anaesthesia (ASA) status and Charlson comorbidity index (CCI) at time of surgery were collected.Results: No significant difference in baseline clinicodemographic characteristics was found between groups. A reduced mean procedure duration was found in the one‐surgeon cohort (424.9 min, SD 127.6) compared to the two‐surgeon cohort (552.4 min, SD 119.2) (mean difference 127.5 min, Cohen d = 1.04). A slightly greater proportion of osteocutaneous free flaps was performed in the two‐surgeon cohort compared to the one‐surgeon cohort (one‐surgeon: 53.5%; two‐surgeon 62.3%). All other secondary quality measures showed nonsignificant differences with the exception of the proportion requiring intraoperative pressors (86.2% in one‐surgeon cohort vs. 74.5% in two‐surgeon cohort, mean difference 11.7%, Cohen d = 0.29).Conclusions: This study demonstrates at least noninferior efficiency and quality outcomes in free flap cases led by single primary surgeons at our institution. The optimal approach to maximise operative efficiency and quality likely differs across surgeons and centres.Level of Evidence: III.


  • Sociodemographic and Clinical Determinants of 12‐Month Decision Regret for Head and Neck Cancer Patients

    by Naomi C. Wang, Uma R. Ramesh, Maria Feucht, Rahul Alapati, Sarah F. Wagoner, Rohit Nallani, Kiran Kakarala, Yelizaveta Shnayder, Chelsea S. Hamill, Kevin J. Sykes, et al.

    Objective: This study aims to identify factors associated with increased decision regret (DR) 12 months following treatment among head and neck cancer (HNC) patients.Study Design: A retrospective observational cohort study.Setting: Patients with newly diagnosed HNC at an academic tertiary care center from 2018 to 2023.Methods: Data from a patient registry assessing quality of life (QOL), DR, social support, and anxiety at initial diagnosis and 12 months post‐treatment were analyzed. Only patients who completed the decision regret questionnaire at 12 months were included.Results: Among 225 participants, 60% experienced mild DR and 28% reported moderate to severe regret. Stronger regret was associated with advanced disease presentation, free flap reconstructive surgery, chemoradiation, and disease recurrence. Patients with more severe regret had lower QOL at baseline and 12 months, higher anxiety at 12 months, and lower social support at 12 months. Multivariable analysis identified multimodal treatment including radiation (adjusted odds ratio [aOR] 3.67, 95% confidence interval [CI] [1.25‐10.78], P = .018), lower 12‐month social support (aOR 1.03, 95% CI [1.00‐1.05], P = .039), and decreases in QOL (aOR 1.03, 95% CI [1.00‐1.06], P = .024) as independent predictors of increased DR.Conclusion: Treatment involving radiation, lower concurrent social support, and diminished QOL are associated with DR 12 months after treatment. This highlights the potential of interventions aimed at enhancing social support, addressing treatment‐related sequelae, and strengthening shared decision‐making to prevent regret. Further studies are needed to elucidate factors driving regret in HNC patient subgroups and assess the efficacy of proposed mitigative interventions.


  • Improving Quality and Value in Head and Neck Reconstruction

    by Kiran Kakarala, Matthew Mifsud, Peter Dziegielewski

  • Open Access

    Association of Social-Ecological Factors With Delay in Time to Initiation of Postoperative Radiation Therapy

    by Tuleen Sawaf, Celina G. Virgen, Bryan Renslo, Nathan Farrokhian, Katherine M. Yu, Shaan N. Somani, Andrés M. Bur, Kiran Kakarala, Yelizaveta Shnayder, Gregory N. Gan, et al.

    Importance: Timely initiation of postoperative radiation therapy (PORT) is associated with reduced recurrence rates and improved overall survival in patients with head and neck squamous cell carcinoma (HNSCC). Measurement of the association of social-ecological variables with PORT delays is lacking.Objective: To assess individual and community-level factors associated with PORT delay among patients with HNSCC.Design, Setting, and Participants: This prospective cohort study carried out between September 2018 and June 2022 included adults with untreated HNSCC who were enrolled in a prospective registry at a single academic tertiary medical center. Demographic information and validated self-reported measures of health literacy were obtained at baseline visits. Clinical data were recorded, and participant addresses were used to calculate the area deprivation index (ADI), a measure of community-level social vulnerability. Participants receiving primary surgery and PORT were analyzed. Univariable and multivariable regression analysis was performed to identify risk factors for PORT delays.Exposures: Surgical treatment and PORT.Main Outcomes and Measures: The primary outcome was PORT initiation delay (>42 days from surgery). Risk of PORT initiation delay was evaluated using individual-level (demographic, health literacy, and clinical data) and community-level information (ADI and rural-urban continuum codes).Results: Of 171 patients, 104 patients (60.8%) had PORT delays. Mean (SD) age of participants was 61.0 (11.2) years, 161 were White (94.2%), and 105 were men (61.4%). Insurance was employer-based or public among 65 (38.5%) and 75 (44.4%) participants, respectively. Mean (SD) ADI (national percentile) was 60.2 (24.4), and 71 (41.8%) resided in rural communities. Tumor sites were most commonly oral cavity (123 [71.9%]), with 108 (63.5%) classified as stage 4 at presentation. On multivariable analysis, a model incorporating individual-level factors with health literacy in addition to community-level factors was most predictive of PORT delay (AOC= 0.78; R2, 0.18).Conclusions and Relevance: This cohort study provides a more comprehensive assessment of predictors of PORT delays that include health literacy and community-level measures. Predictive models that incorporate multilevel measures outperform models with individual-level factors alone and may guide precise interventions to decrease PORT delay for at-risk patients with HNSCC.


  • Pilot randomized, controlled, preoperative intervention for nutrition trial in head and neck cancer

    by Kevin J. Sykes, Heather Gibbs, Nathan Farrokhian, Anna Arthur, John Flynn, Yelizaveta Shnayder, Kiran Kakarala, Rohit Nallani, Joshua B. Smith, Joseph Penn, et al.

    Background: Several prospective studies report improved outcomes with pretreatment nutrition interventions prior to radiation therapy for head and neck cancer (HNC), but none have assessed similar interventions before surgery for HNC.Methods: POINT, a pilot randomized controlled trial, was conducted to evaluate a multimodal nutrition intervention. Patients undergoing primary surgery with free flap reconstruction for HNC were randomly assigned to the control arm or a preoperative multimodal nutrition intervention.Results: POINT included 49 patients. Nutrition risk scores did not change significantly for either the intervention or control group. Control patients had a significant decrease in body weight in the preoperative period (p < 0.001). Conversely, weight among intervention patients did not significantly decrease (p = 0.680). The intervention mitigated weight loss in patients with dysphagia (p = 0.001).Conclusions: Preoperative nutrition optimization shows potential to reduce weight loss normally experienced by patients with head and neck cancer prior to surgical extirpation, especially among those with subjective dysphagia.


  • Post‐operative Outcomes in Pediatric Patients Following Facial Reconstruction With Fibula Free Flaps

    by Allison A. Slijepcevic, Mark K. Wax, Matthew Hanasono, Yadranko Ducic, Daniel Petrisor, Carissa M. Thomas, Yelizaveta Shnayder, Kiran Kakarala, Patrik Pipkorn, Sidharth V. Puram, et al.

    Educational Objective: Assess outcomes of pediatric facial reconstruction with fibula free flaps.Objectives: Free flap reconstruction of complex maxillofacial defects in pediatric patients is rare. Post‐operative complications, donor site morbidity, impact on craniofacial growth, and oro‐dental rehabilitation are unknown. Our study assesses the outcomes of pediatric maxillofacial reconstruction with composite fibula free flaps.Study Design: Retrospective chart review.Methods: Multi‐institutional retrospective chart review from 2000 to 2020 on pediatric patients undergoing maxillomandibular reconstruction with fibula free flaps.Results: Eighty‐seven patients underwent 89 surgeries; 5 maxillary and 84 mandibular defects. Median age: 12 years. Defects were acquired following resection of sarcoma/carcinoma 44% or benign tumors 50%. 73% of cases had immediate free flap reconstruction. Closing osteotomies were reported in 74%; 1 in 40%, 2 in 27%, and more than 2 in 6.7%. Hardware was used in 98% and removed in 25%. 9.2% demonstrated long‐term hardware exposure, greater than 3 months following reconstruction. Short‐term complications: wound infection 6.7%, flap salvage/failure 2.2%, fistula 1.1%, and compromised craniofacial growth: 23%. Two patients developed trismus. Long‐term fibula donor site complications: hypertrophic scarring: 3.4%, dysesthesia: 1.1%, and long‐term gait abnormality: 1.1%. Dental rehabilitation was performed in 33%. Post‐operative speech outcomes showed 94% with fully intelligible speech.Conclusion: Pediatric maxillary and mandible defects repaired with fibula free flaps demonstrated complication rates comparable to the adult free flap population. Long‐term follow‐up did not demonstrate adverse outcomes for craniofacial growth. Hardware for flap retention was utilized and remained in place with minimal exposure. Post‐operative gait abnormality is rare.Level of Evidence: 3 Laryngoscope, 133:302–306, 2023


  • Open Access

    Sarcopenia and Treatment Toxicity in Older Adults Undergoing Chemoradiation for Head and Neck Cancer: Identifying Factors to Predict Frailty

    by Ryan T. Morse, Rohit G. Ganju, Gregory N. Gan, Ying Cao, Prakash Neupane, Kiran Kakarala, Yelizaveta Shnayder, Christopher E. Lominska

    This study was performed to identify treatment related toxicities in older adults undergoing concurrent chemoradiotherapy for head and neck cancer and nutritional and skeletal muscle measures that might identify frailty. Imaging analysis was done with the following skeletal muscle measurements: skeletal muscle index (SMI), skeletal muscle density (SMD), and skeletal muscle gauge (SMG). Patients were dichotomized by age into younger (p < 0.01), as were low SMD (57.8% vs. 37.3%, p = 0.012) and low SMG (76.1% vs. 44.2%, p < 0.01), despite having similar BMIs (27.3 kg/m2 versus 27.7 kg/m2, p = 0.71). Older patients were significantly more likely to experience chemotherapy toxicity than younger patients (54.9% versus 32.3%, p < 0.01). On multivariate analysis age (p < 0.01), current smoking status (p < 0.01), and low SMI (p < 0.01) remained as significant predictors for missed chemotherapy cycles or discontinuation. Older patients were more likely to require ≥5-day radiation breaks than younger patients (27.5% versus 8.6%, p < 0.01). On multivariate analysis, age (p < 0.01), low albumin status (p = 0.03), and low SMI (p = 0.04) were identified as predictors of prolonged radiation treatment breaks. Based on the results of our study, sarcopenia may be used as an additional marker for frailty alongside traditional performance status scales.


  • Open Access

    Telemedicine for head and neck cancer surveillance in the COVID‐19 era: Promise and pitfalls

    by Scott Fassas, Emily Cummings, Kevin J. Sykes, Andrés M. Bur, Yelizaveta Shnayder, Kiran Kakarala

    Background: The coronavirus disease 2019 pandemic has led to increased telemedicine visits. This study examines current preferences and barriers for telemedicine among patients with head and neck cancer.Methods: Single institution retrospective analysis of 64 patients scheduling visits with the head and neck surgical oncology clinic at a tertiary academic medical center. Data were collected detailing patient preferences and barriers regarding telemedicine appointments. Patients electing to participate in telemedicine were compared to those preferring in‐person appointments.Results: Most patients (68%) were not interested in telemedicine. Preference for in‐person examination was the most common reason for rejecting telemedicine, followed by discomfort with or limited access to technology. Patients elected telemedicine visits to avoid infection and for convenience.Conclusions: When given a choice, patients with head and neck cancer preferred in‐person visits over telemedicine. Although telemedicine may improve health care access, patient preferences, technology‐related barriers, and limitations regarding cancer surveillance must be addressed moving forward.